Apollomics
An innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies.
Launch date
Employees
Market cap
CAD20.4m
Enterprise valuation
(CAD9m) (Public information from Sep 2024)
Share price
$0.132 APLM
Pleasanton California (HQ)
Authorizing premium user...